Hemophilia Drugs Market 2019 Analysis, Exhibit 6.0% CAGR and Remarkable Growth Rate forecast till 2025

Hemophilia Drugs Market is projected for better diagnosis because patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process, Hemophilia Drugs Industry exhibit a 6.0% & strong growth in the coming years

pune, india - May 16, 2019 /MarketersMedia/ —

The Global Hemophilia Drugs Market covered a value of US$ 9875.4 Mn in the year 2017 and is anticipated to reach US$ 15830.3 Mn by 2025. Furthermore, the global market for hemodialysis is expected to report a CAGR of 6.0% during the forecast period. The above information was published in a report, titled “Hemophilia Drugs Market Size, Share and Global Trend by Disease Indication (Hemophilia A, B & C), Therapy Type (Recombinant Therapy, Plasma therapy & Others), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2025.”

The rising prevalence of severe diseases is one of the major concerns in the healthcare industry. Among these disorders, patients with hemophilia suffer from an abnormal blood loss and this weakens their blood clotting process. Companies are introducing novel hemophilia drugs and therapies to fulfil the unmet needs of patients and maintain their quality of life. A lead analyst at Fortune Business Insights said, “Companies are building expansion strategies to develop new hemophilia drugs so as to offer better diagnosis.”

Among disease indications, hemophilia A is projected to exhibit a strong growth in the coming years. In addition to this, this segment covered a share of 85% in the global hemophilia drugs market in 2017. This is mainly attributable to the rising pool patients suffering from hemophilia across the world. Also, rising initiatives at developing and commercializing new products for the effective treatment of hemophilia is driving this segment’s growth. Following hemophilia A, hemophilia B drugs are also expected to grow at a considerable rate in the years to come.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemophilia-drugs-market-100068

Asia Pacific to Grow at a Rapid Pace with Rising Number of Hemophilia Patients

North America is projected to emerge dominant in the global hemophilia drugs market during the forecast period. This is mainly ascribable to the rising prevalence of hemophilia A and B, especially in countries such as Canada and the U.S. Moreover, in 2017, North America market for hemophilia drugs covered a value of US$ 3,684.7 Mn. Trailing North America, Europe is the second-leading region in the global hemophilia drugs market. The growth in this region is attributable to the rising healthcare budgets by governments and initiatives by governments to promote hemophilia drugs treatment. On the other hand, the hemophilia drugs market in Asia Pacific is likely to expand at a higher CAGR between 2017 and 2025 on account of rising number of patients suffering from hemophilia especially in countries such as China and India.

Rising Awareness About Hemophilia to Augment the Demand

The primary factor augmenting the hemophilia drugs market is the recent developments in hemophilia treatment. A lead analyst at Fortune Business Insights said “Several new drugs are expected to enter the global market in the coming years.” Also, hemophilia surgical management is gaining traction on account of increasing awareness about hemophilia across the world. Moreover, governments are planning to conduct awareness initiatives to spread knowledge regarding the use of hemophilia treatment and drugs This, in turn, is expected to drive the hemophilia drugs market over the next few years. The genetic evolution is leading to rising incidences of bleeding disorders across the world. This will further lead to hemophilia drug development in the next few years to come. As per the study conducted by the National Hemophilia Foundation or NHF in 2015, about 1% of the U.S. population is likely to suffer from a disease called von Willebrand, hence rising the need for hemophilia treatment drugs.

Pfizer Introduced Gene Therapy to Address Unmet Patient’s Needs

Some of the leading players presently operating in the global market for hemophilia drugs are Grifols SA, Bioverativ Inc., FERRING LÄKEMEDEL AB, Aptevo Therapeutics, Hoffmann-La Roche Ltd, Novo Nordisk, Pfizer, Inc. and CSL Behring. In 2018, companies such as Novo Nordisk, Takeda Pharmaceutical Company Ltd., and F. Hoffmann-La Roche Ltd covered more than half of the share in the global hemodialysis market as per revenue. In 2017, Pfizer, Inc. collaborated with Sangamo Therapeutics, Inc. to commercialize and develop gene therapy programs. The aim was to utilize these programs for Hemophilia A drugs.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemophilia-drugs-market-100068

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemophilia-drugs-market-2019-analysis-exhibit-60-cagr-and-remarkable-growth-rate-forecast-till-2025/513243

Source: MarketersMedia

Release ID: 513243

Related News

Ex-NFL player faces trial in death of girlfriend's child

May 23, 2019

LAS VEGAS — A former pro football player was ordered Wednesday to stand trial on murder and child abuse charges in the death of his girlfriend's 5-year-old daughter soon after they moved into his Las Vegas apartment this year. A judge told former NFL and Canadian Football League running back Cierre Marcelle Wood, 28, that testimony from a detective, firefighter and medical examiner convinced her that Wood and the child's mother, Amy Taylor, inflicted physical injuries that caused the death of La'Rayah Davis. "We know who was in that apartment during that period of time," Las Vegas Justice of the...

1st of 5 women to testify at ex-NFL player's rape trial

May 23, 2019

VISTA, California — Prosecutors plan to call the first of five women to testify Tuesday at the rape trial of former NFL player Kellen Winslow Jr., whose accusers include a 54-year-old who got a ride from him hitchhiking and a 59-year-old who was homeless when they met. Meanwhile defense lawyers argued the sex was consensual and asked jurors not to judge the married father for his "cheating ways." The son of a Hall of Famer did not show any emotion during opening statements Monday at his trial in Southern California. His father, a former star with the San Diego Chargers,...

Eagles' Chris Long announces retirement after 11 NFL seasons

May 23, 2019

PHILADELPHIA — Eagles defensive lineman Chris Long announced his retirement from football Saturday night, ending an 11-year NFL playing career that included winning two Super Bowl titles and the Walter Payton Man of the Year Award. Long posted his decision on Twitter , with a tweet that included a picture of his right hand holding up a red cup with a grassy field, trees and mountains in the background. "Cheers," Long wrote. "Been a hell of a journey. Eleven years and I can honestly say I put my soul into every minute of it. Highs and lows. I've seen them...

Ex-Oregon football star stops armed student at Oregon school

May 23, 2019

PORTLAND, Ore. — A former college football standout at the University of Oregon was credited Friday with tackling an armed student at a Portland, Oregon, high school before anyone was injured. Keanon Lowe, who is now a football and track coach and a security guard at Parkrose High School, told reporters as he was leaving a police interview late Friday that he was tired but relieved at the outcome, The Oregonian/OregonLive reported. There are no other suspects. Police declined to release the student's name and said they were still trying to determine if he fired any shots. Police spokesman Sgt....

Bucks have Milwaukee dreaming of first title since '71

May 23, 2019

MILWAUKEE — Hunter Trimmel couldn't give away his season tickets to Milwaukee Bucks games five years ago. Losing season after season made the Bucks almost an afterthought in Wisconsin, where most teams live in the shadow of the Green Bay Packers. But now the Bucks are the hottest ticket in town, with a glittery new arena and a young superstar that has the team knocking on the door of the NBA Finals. Game 1 of the Eastern Conference final against Toronto is Wednesday night. Trimmel, 37, was among hundreds of fans flocking to the plaza outside Fiserv Forum last week...

Broaden News

Replay Wall delivers the most accurate sports news to you with experts’ voice. We aim to bring every sports fan together here even if you’ve missed the game.

Contact us: sales@replaywall.com

Bowl Championship Series Professional Football Arena Football CFL Football NFL Football Youth Football Press Releases Broaden News